US$ 20.57
amgen glp-1 drug Will 2 incretin drugs be better than 1 to for weight loss & to prevent weight regain? @Amgen thinks so, releases @Nature phase 1 study of AMG 133 (maridebart cafraglutide) a combination Redefining Obesity Care: The GLP-1
Description
In the STEP clinical trials, overweight adults without diabetes lost an average of around 1415% of their body weight after 68 weeks of treatment

Acute photodistributed exanthematous pustulosis associated with liraglutide treatment

It wins decisively, and for many people this single factor determines the entire decision

16.0%, aHR: 0.73, 95% CI 0.66, 0.80) in patients with diabetes and acute kidney disease when compared to non-users

We all have experienced that loss of appetite during stressful situations when the thought of eating food just doesnt cross the mind

N Engl J Med (2015) 373(1):1122
